The Supreme Court has rejected a challenge of the Food & Drug Administration’s approval and regulation of mifepristone, preserving access to one of two...
On the latest 51%, we continue our series on endometriosis, speaking with doctors, patients, advocates, and researchers about a disease that impacts roughly 1...
On this week’s 51%, we wrap our series speaking with women religious leaders and scholars. Dr. Sh. Haifaa Younis discusses her work at the...
